Correction to: Spanish transcultural adaptation and validation of the English version of the compliance questionnaire in rheumatology

Salgado, Eva; Fernández, José Ramón Maneiro; Vilas, A. Souto; Gómez-Reino, Juan J.

doi:10.1007/s00296-018-4015-3

Cited by 2 publications

(3 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The majority of studies use questionnaires, among which the most commonly used are the Haynes-Sackett24 and the Morisky-Green questionnaires 25. In the case of rheumatic diseases, there is a specific questionnaire, the CQR, used in this study and validated in patients with inflammatory rheumatic diseases against a medication electronic monitoring system 15–17. Therefore, a first cautionary message about any study of adherence is to first understand the definition and measure used; otherwise, comparisons will be difficult 26.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Multilevel factors predict medication adherence in rheumatoid arthritis: a 6-month cohort study

2021

View full text Add to dashboard Cite

Non-adherence challenges efficacy and costs of healthcare. Knowledge of the underlying factors is essential to design effective intervention strategies.ObjectivesTo estimate the prevalence of treatment adherence in rheumatoid arthritis (RA) and to evaluate its predictors.MethodsA 6-month prospective cohort study of patients with RA selected by systematic stratified sampling (33% on first disease-modifying rheumatic drug (DMARD), 33% on second-line DMARD and 33% on biologics). The outcome measure was treatment adherence, defined by a score greater than 80% both in the Compliance Questionnaire in Rheumatology and the Reported Adherence to Medication scale, and was estimated with 95% CIs. Predictive factors included sociodemographic, psychological, clinical, drug-related, patient–doctor relationship related and logistic. Their effect on 6-month adherence was examined by multilevel logistic models adjusted for baseline covariates.Results180 patients were recruited (77% women, mean age 60.8). The prevalence of adherence was 59.1% (95% CI 48.1% to 71.8%). Patients on biologics showed higher adherence and perceived a higher medication need than the others; patients on second-line DMARDs had experienced more adverse events than the others. The variables explaining adherence in the final multivariate model were the type of treatment prescribed (second-line DMARDs OR=5.22, and biologics OR=3.76), agreement on treatment (OR=4.57), having received information on treatment adaptation (OR=1.42) and the physician perception of patient trust (OR=1.58). These effects were independent of disease activity.ConclusionTreatment adherence in RA is far from complete. Psychological, communicational and logistic factors influence treatment adherence in RA to a greater extent than sociodemographic or clinical factors.

show abstract

Section: Discussionmentioning

confidence: 99%

“…The primary endpoint was adherence at 6 months of follow-up, evaluated by the Compliance Questionnaire Rheumatology (CQR)15–17 and the Reported Adherence to Medication (RAM) scale 18. The CQR is a rheumatology-specific instrument to measure patient compliance to drug regimens.…”

Section: Methodsmentioning

confidence: 99%

Multilevel factors predict medication adherence in rheumatoid arthritis: a 6-month cohort study

2021

View full text Add to dashboard Cite

show abstract

“…However, frequently non disease-specific, general indexes such as Barthel and Lawton-Brody (LB) are used to establish disability in legal environtments and in emergency rooms. Few studies have compared specific vs. generic questionnaires in rheumatic patients (1).…”

mentioning

confidence: 99%

Ab1307 study of Concordance and Equivalence Among Barthel, Lawton, Haq and Basfi Questionnaires in Rheumatoid and Spondyloarthritis Patients

Serrano

Saez

Conesa

et al. 2019

Abstracts Accepted for Publication

View full text Add to dashboard Cite

Background:Assessment of functional capacity of patients is usually performed using disease-specific questionnaires for rheumatoid arthritis (HAQ) and for axial spondyloarthropathies (BASFI). However, frequently non disease-specific, general indexes such as Barthel and Lawton-Brody (LB) are used to establish disability in legal environtments and in emergency rooms. Few studies have compared specific vs. generic questionnaires in rheumatic patients (1).Objectives:To assess the equivalence between disability questionnaires of generic type, applicable to general population and various diseases (Barthel and LB), with specific questionnaires for rheumatic diseases (HAQ and BASFI).Methods:A cross-sectional study was conducted in consecutive outpatients with inflammatory rheumatic diseases (rheumatoid arthritis, psoriatic arthritis, spondyloarthropathies) in usual daily clinical practice in a rheumatology clinic of a tertiary hospital.The patients self-completed the questionnaires (Barthel, LB, HAQ, and BASFI) in a single session. HAQ was only filled by peripheral arthritis patients, while BASFI was only given to spondyloarthropathy subjects. Scores were also computed for SDAI, DAS28 and BASDAI in most patients. Intraclass correlation was used to measure concordance between questionnaires.Results:A total of 214 patients where studied. There was good correlation between the scores of the indexes studied, especially between the two general questionnaires (R = 0.45 p <0.01). We observed a high ceiling effect in the scores of both Barthel, (70% of patients obtained values> 95 over a maximum of 100) and Lawton-Brody (60% had values> 23 over a maximum of 24) tests. The disease-specific questionnaires showed a less skewed distribution. The agreement between Barthel’s and Lawton’s tests was significant when measured by the intraclass correlation (R = 0.48 p <0.01). However, we could not find any significant correlation between the generic questionnaires and the HAQ questionnaire or the BASFI (R < 0.3).Conclusion:The Barthel and Lawton-Brody indices show an important ceiling effect in rheumatic patients, and seem to evaluate dimensions of health other than rheumatic questionnaires such as HAQ and BASFI, and thus they are not interchangeable. This point must be taken into account when performing medicolegal or emergency room assessments. Our result is in line with other previous studies(1)Reference[1] Zochling J, Stucki G, Grill E, Braun J. A comparative study of patient-reported functional outcomes in acute rheumatoid arthritis. J Rheumatol 2007;34(1):64–9.Disclosure of Interests:None declared

show abstract

Correction to: Spanish transcultural adaptation and validation of the English version of the compliance questionnaire in rheumatology

Abstract: In the original published article, the family name was incorrectly tagged for two co-authors. The correct family names of authors José Ramón Maneiro Fernández is Maneiro Fernández and Alejandro Souto Vilas is Souto Vilas.

Cited by 2 publications

References 0 publications

Multilevel factors predict medication adherence in rheumatoid arthritis: a 6-month cohort study

Multilevel factors predict medication adherence in rheumatoid arthritis: a 6-month cohort study

Ab1307 study of Concordance and Equivalence Among Barthel, Lawton, Haq and Basfi Questionnaires in Rheumatoid and Spondyloarthritis Patients

Contact Info

Product

Resources

About